drugset / Trial / NCT00427804
Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is a pilot study to determine whether patients with TNFα excess have decreased calcium absorption in response to calcitriol (1,25-dihydroxyvitamin D, the active form of vitamin D) compared to normal controls. This initial pilot study is being done to determine if it is feasible to conduct a study where TNFα could be blocked (e.g., by anti-TNFα therapy such as Enbrel® or Remicade®) to improve vitamin D dependant calcium absorption and thus bone health.
Timeline
- Start
- 2007-01
- Primary completion
- 2009-08
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcitriol | Small molecule | 0.25 ug | Oral |
| Subject | Calcitriol | Small molecule | 0.5 ug | Oral |